MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
91 hedge funds and large institutions have $149M invested in Melinta Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 10 closing their positions.
Holders
91
Holders Change
+4
Holders Change %
+4.6%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
39
Reduced
18
Closed
10
Calls
$371K
Puts
$476K
Net Calls
-$105K
Net Calls Change
-$94K
Top Buyers
1 |
SCM
1
Stonepine Capital Management
Bend,
Oregon
|
$7.74M |
2 |
2
BlackRock
New York
|
$9.58M |
3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$6.39M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$1.93M |
5 |
5
First Manhattan
New York
|
$6.2M |